{
  "report_rows": [
    {
      "kpi": "Total Billings (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$2.22B vs. cons $2.141B",
      "confidence": "HIGH"
    },
    {
      "kpi": "Product Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$670M vs. cons $638M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP Diluted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$0.78 vs. cons $0.747",
      "confidence": "HIGH"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Billings (FY2026)",
      "prediction": "BETTER",
      "answer": "guide mid ~$9.20B vs. cons $8.942B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Non-GAAP EPS (FY2026)",
      "prediction": "BETTER",
      "answer": "guide mid ~$3.22 vs. cons $3.156",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Service Revenue Inflection (qualitative)",
      "prediction": "BETTER",
      "answer": "H2 2026 reaffirmed with higher conviction vs. prior vague language",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 4.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 7.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 estimate revisions track FY raise; modest follow-through capped by valuation at 52x NTM FCF",
  "day5_confidence": "MEDIUM"
}